Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
about
Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumorsBifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesThe Promise of Integrins as Effective Targets for Anticancer AgentsNoninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDOncologic Angiogenesis Imaging in the clinic---how and why.Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsionsPreclinical molecular imaging of tumor angiogenesis.Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumorsPeptide-mediated cellular uptake of cryptophane.Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyImaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides.Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy.Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokineticsPeptide targeting of platinum anti-cancer drugsSynthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand(44)Sc: an attractive isotope for peptide-based PET imaging.Molecular imaging of angiogenesis with SPECT.Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.Heterobivalent ligands target cell-surface receptor combinations in vivo.Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.Positron emission tomography imaging of cancer biology: current status and future prospectsIntegrin alpha v beta 3-targeted imaging of lung cancer.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTSystemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor modelsEffects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of gliomaImaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents.Review of functional/anatomical imaging in oncology.Stroma targeting nuclear imaging and radiopharmaceuticals.Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.Synthesis and characterization of αvβ₃-targeting peptidomimetic chelate conjugates for PET and SPECT imaging.Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.Imaging metastasis using an integrin-targeting chain-shaped nanoparticle.One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging.
P2860
Q22000766-219BD277-AD19-46CC-9177-73BAB3C13CEBQ24649091-A1275AC6-91C2-4FBA-A0BE-539539DF9081Q24801503-62EEE45E-09C1-423E-9223-EF76266C3F99Q24805375-C7EA782E-D668-453D-9677-1F16AAFD5430Q30472751-348A72D3-8D04-410F-8AA7-97BE0531E3AAQ30474759-2A4FFE2A-BDD7-4905-86D1-79E71A9BDE09Q30475818-5FBAA7CE-5532-46BD-B947-CD71F26C80FEQ33215681-C7153630-6E3A-4037-8550-8C04997ABA26Q33237917-1CA2A454-3834-4183-B8A1-37F61A6CE0A0Q33377228-BA4F9BC7-FC0B-473B-92CD-D6CB5ABC177BQ33586660-E83A58D0-1F07-4027-B40F-88E220910D54Q33668360-179539A4-EB83-4E81-99AE-91511AF881BFQ33814126-2405ACFD-2565-4303-90FC-2DE67DE0FEBFQ33851309-8950149F-BAB1-4021-AD38-D533D23FB641Q33864330-B702024C-B074-4A0A-86B3-A7638B29B25EQ33925952-30191232-D119-4634-A7A0-03FD7C4DC01EQ33937941-51A3FF7A-698E-4FBA-94FE-CB27D851B749Q33979930-31EE0034-2932-413C-95B3-DA6CBB0BCABAQ34028144-ADCCDDF1-2D4B-4B31-8C87-CCFD01BBCD15Q34040149-453AA754-E7DD-434B-BB05-8D9092250322Q34159304-73E8E281-6D68-4BA4-AA3F-C4DDF094A218Q34317386-4314E740-2175-4D03-942C-64321B58DD16Q34380380-3CAC7F49-07B9-49B6-A4FD-E14706E96072Q34385892-0E72FD4F-97CB-41A3-B361-DFA4263CC231Q34697688-32FBE21A-2009-4A9C-B8FF-D5EE6F4F451AQ34768362-6080A6FF-964F-453A-9E27-FFB0FBD17EDCQ34912643-7D84F648-D51E-4857-9582-20AF2417C1C8Q35016398-14DD32D5-4F15-4529-A8D0-DF3DF8353893Q35255956-388CF19B-70EA-40A5-88A8-8D85D13C742CQ35335414-3395A76E-5B86-4B01-B528-643648B40424Q35561603-6365DCDC-E217-434C-9A66-5EEBC46D85C8Q35602386-62F61BE6-1D18-448C-9A09-15AA19F08F89Q35760732-9E8D126A-3918-458D-A919-45A189B9F0FEQ35809612-96C7F373-B8BC-44B9-9CCC-C76B2F8FAE1AQ35999606-52770C35-52FE-4908-AB4B-430E908479C0Q36113183-F5912256-F1B9-407B-B1D4-4655F2274899Q36177190-686AE5EE-016D-4847-9E8E-91CF95F4F851Q36306814-F0BA364E-3612-4E70-A985-8CEC8B20EC5BQ36366404-C12B250A-D8F2-47A0-B896-F76B2FB29221Q36533804-9A48505B-00F9-4C74-B6A2-9AA9D8575611
P2860
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@ast
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@en
type
label
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@ast
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@en
prefLabel
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@ast
Glycosylated RGD-containing pe ...... ing with improved biokinetics.
@en
P2093
P1476
Glycosylated RGD-containing pe ...... ging with improved biokinetics
@en
P2093
Burkhart F
Goodman SL
Schwaiger M
Senekowitsch-Schmidtke R
P304
P407
P577
2001-02-01T00:00:00Z